Arcus Biosciences Inc
NYSE:RCUS

Watchlist Manager
Arcus Biosciences Inc Logo
Arcus Biosciences Inc
NYSE:RCUS
Watchlist
Price: 25.07 USD -2.83% Market Closed
Market Cap: 3.4B USD

Wall Street
Price Targets

RCUS Price Targets Summary
Arcus Biosciences Inc

Wall Street analysts forecast RCUS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RCUS is 35.8 USD with a low forecast of 16.16 USD and a high forecast of 58.8 USD.

Lowest
Price Target
16.16 USD
36% Downside
Average
Price Target
35.8 USD
43% Upside
Highest
Price Target
58.8 USD
135% Upside
Arcus Biosciences Inc Competitors:
Price Targets
ADOC
Adocia SA
124% Upside
688336
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
23% Upside
688687
Beijing Kawin Technology Share-holding Co Ltd
88% Upside
XOMA
XOMA Corp
125% Upside
CUV
Clinuvel Pharmaceuticals Ltd
104% Upside
MRSN
Mersana Therapeutics Inc
20% Upside
ALXO
ALX Oncology Holdings Inc
108% Upside
IMTX
Immatics NV
84% Upside

Revenue
Forecast

Revenue Estimate
Arcus Biosciences Inc

For the last 7 years the compound annual growth rate for Arcus Biosciences Inc's revenue is 111%. The projected CAGR for the next 3 years is -8%.

111%
Past Growth
-8%
Estimated Growth
Estimates Accuracy
6%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Arcus Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Arcus Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-55%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RCUS's stock price target?
Price Target
35.8 USD

According to Wall Street analysts, the average 1-year price target for RCUS is 35.8 USD with a low forecast of 16.16 USD and a high forecast of 58.8 USD.

What is Arcus Biosciences Inc's Revenue forecast?
Projected CAGR
-8%

For the last 7 years the compound annual growth rate for Arcus Biosciences Inc's revenue is 111%. The projected CAGR for the next 3 years is -8%.

Back to Top